Delays in New Product Planning, Development and Commercialization
First written in FY2020. 3 of 4 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2025: 3 of 22 companies on the "Worse" side.
44 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「The Company develops products based on detailed analysis and forecasts of market needs. It is strengthening its R&D capabilities and promoting collaboration with external research institutions to create innovative products. It is also working to assess market response through small-scale test sales of new products.」
It continues to recognize the risks of delays in new-product development and market acceptance, and plans to address them through market analysis, collaboration with external research institutions and test sales. - FY2023RestatedAnnual report
「The period from planning these products through development and commercialization can range from several months to more than one year.」
It continues to describe the risk of delays requiring several months to more than 1 year for the planning, development and commercialization of new products. - FY2021RestatedAnnual report
「The period from planning these products through development and commercialization can range from several months to more than one year.」
It continues to describe the risk of delays requiring several months to more than one year for the planning, development and commercialization of new products. - FY2020First statedAnnual report
「The period from planning these products through development and commercialization can range from several months to more than one year.」
While expanding its product portfolio, it identifies longer development times and delays to plans as risks.